The CRH family of neuropeptides, including CRH and urocortins, plays pivotal roles in the regulation of physiological and behavioral stress responses in vertebrates. In this study, we identified a previously undescribed member of the CRH family of peptides in a teleost fish species (medaka; Oryzias latipes) and named this peptide teleocortin (Tcn). Medaka Tcn is a 41-amino acid polypeptide derived from the C terminus of a larger precursor protein that is encoded by a 2-exon gene, thus sharing common structural features with known CRH family peptides. tcn was found exclusively in teleost fish. Phylogenetic analysis suggested that tcn probably has an ancient origin but was lost from the tetrapod lineage shortly after the divergence of the teleost and tetrapod lineages. In the medaka brain, tcn was expressed in nuclei of the telencephalon, preoptic area, hypothalamus, tegmentum, and isthmic region. Because none of these nuclei have been implicated in the control of ACTH secretion from the pituitary, Tcn may exert its effects centrally in the brain rather than via stimulation of the pituitary-adrenal/interrenal axis. Most, if not all, tcn-expressing neurons also expressed crh, suggesting that Tcn and Crh share common physiological functions. Moreover, Tcn activated Crh receptors 1 and 2 with equivalent or slightly higher potency than Crh, further suggesting that these peptides share common functions. Taken together, these data identified Tcn as a novel, teleost-specific member of the CRH family of peptides that may act centrally with Crh to regulate physiological and behavioral stress responses. A ll living organisms have mechanisms for coping with various stress conditions. CRH, a 41-amino acid neuropeptide, is the primary regulator of endocrine, autonomic, and behavioral responses to stress in vertebrates (1, 2). CRH produced in the hypothalamus activates the endocrine stress response system, called the hypothalamicpituitary-adrenal/interrenal axis, by stimulating the secretion of ACTH from the pituitary. CRH is also produced in several extrahypothalamic brain regions, where it serves as a neurotransmitter/neuromodulator that mediates autonomic and behavioral responses to stress, including the induction of aggression and arousal and the suppression of food intake and sexual activity (1, 2).
A ll living organisms have mechanisms for coping with various stress conditions. CRH, a 41-amino acid neuropeptide, is the primary regulator of endocrine, autonomic, and behavioral responses to stress in vertebrates (1, 2) . CRH produced in the hypothalamus activates the endocrine stress response system, called the hypothalamicpituitary-adrenal/interrenal axis, by stimulating the secretion of ACTH from the pituitary. CRH is also produced in several extrahypothalamic brain regions, where it serves as a neurotransmitter/neuromodulator that mediates autonomic and behavioral responses to stress, including the induction of aggression and arousal and the suppression of food intake and sexual activity (1, 2) .
Since the first isolation of CRH from the ovine hypothalamus in 1981 (3), 3 structurally related peptides, termed urocortins (UCNs), have been identified in vertebrates: UCN (including the peptides known as urotensin 1 (uts1) in teleost fish and sauvagine in frogs), UCN2, and UCN3, which are composed of 40 or 41, 38, and 38 amino acids, respectively (4 -7). These 4 peptides constitute the CRH family of neuropeptides, and all are highly conserved from teleost fish to mammals (8) . UCNs appear to play an essential role in the stress-recovery process (1) . CRH and UCNs exert their stress-relevant effects by binding to 2 common G protein-coupled receptors, CRH receptor (CRHR) 1 and CRHR2 (9, 10) , with different affinities. Because both receptors are primarily coupled to Gs proteins, intracellular cAMP increases upon their activation. CRH has a higher affinity for binding to CRHR1 than for binding to CRHR2, whereas UCN has similar affinity for binding to both receptors (4, 10) . In contrast, UCN2 and UCN3 are highly selective for CRHR2 and have virtually no activity at CRHR1 (5, 7) . Recently, an additional member of the CRH family, designated CRH2, has been identified in silico in the genome sequence of elephant sharks (Callorhinchus milii), although not yet experimentally characterized (11) .
Because teleost fish have a pivotal phylogenetic position and unique physiological and life-history traits, they provide valuable opportunities for increasing our understanding of the vertebrate stress response and those underlying mechanisms that involve CRH family peptides. However, in this area of research, only limited efforts have been made to study teleosts (12) (13) (14) (15) (16) (17) . In this study, we identified a novel, teleost-specific member of the CRH family of neuropeptides, which we designated teleocortin (Tcn). We also characterized the evolutionary, physiological, and biochemical aspects of Tcn.
Materials and Methods

Animals
All animals used in this study were treated in accordance with the guidelines of the Committee on Life Sciences at The University of Tokyo. Medaka fish (Oryzias latipes) of the d-rR strain were bred and maintained at 28°C with a 14-hour light, 10-hour dark photoperiod. They were fed 3 or 4 times per day with live brine shrimp and commercial pellet food. Sexually mature adults at 3-5 months of age were sampled 1-3 hours after the onset of light and used for analyses.
Identification and structural analysis of tcn
A search of the medaka genome assembly in Ensembl identified a previously uncharacterized predicted gene (gene ID, EN-SORLG00000006816) that bears some sequence similarity to CRH and UCN genes. To identify and isolate the transcript of this gene, here named tcn, rapid amplification of cDNA ends was performed on medaka brain poly(A) ϩ RNA using the Marathon cDNA Amplification kit (Takara Bio) as described previously (18) . The gene-specific primers TCN-F1 (5Ј-GGAGGCACAGCTCCA-GATCCATCCT-3Ј)/TCN-F2 (5Ј-CTCTGCTGCAGCTCTCA-CAGCACCT-3Ј) and TCN-R1 (5Ј-GGGTGAACGTCCAGCT-CAGACAGGA-3Ј)/TCN-R2 (5Ј-CTCAGACAGGAGGAGGTC-ATTTTCCAA-3Ј) were designed and used as primary/nested PCR primers for 3Ј-and 5Ј-rapid amplification of cDNA ends, respectively. The nested PCR products were subcloned into the pGEMTeasy vector (Promega) and sequenced in both directions using the BigDye Terminator v3.1 Cycle Sequencing kit in Applied Biosystems 3730xl DNA/3130xl Genetic Analyzers (Life Technologies). Each part of the sequence was determined from at least 4 independent clones.
The deduced amino acid sequence of medaka tcn was analyzed for the presence of specific domains or motifs using InterProScan 5 (http://www.ebi.ac.uk/Tools/pfa/iprscan5/) and SignalP 4.1 (http://www.cbs.dtu.dk/services/SignalP/). Its exon/ intron structure was determined by comparing the cDNA sequence with the genomic sequence available in Ensembl.
Phylogenetic and synteny analyses of tcn
The medaka tcn sequence was used to query the GenBank and Ensembl databases for the presence of possible orthologs in other species. The deduced amino acid sequences of the identified genes were aligned with those of other known and predicted CRH family genes using ClustalW. The resulting alignment was used to construct a bootstrapped (1000 replicates) neighborjoining tree (http://clustalw.ddbj.nig.ac.jp/index.php). The species names and GenBank accession numbers (or protein IDs/ genomic scaffold numbers in Ensembl) of the sequences used in the analysis are listed in Supplemental Table 1 . Synteny data for the tcn, crh, and uts1 loci were retrieved from the Ensembl genome assemblies.
Localization of tcn expression in the medaka brain
Whole brains with the pituitaries attached (n ϭ 5) were fixed in 4% paraformaldehyde and embedded in paraffin. Serial coronal sections, each 10 m in thickness, were cut throughout the brains, from the olfactory bulb to the anterior medulla. A 778-bp fragment corresponding to nucleotides 87-864 of the medaka tcn cDNA was PCR amplified and labeled with digoxigenin (DIG) using DIG RNA Labeling Mix and T7 RNA polymerase (Roche Diagnostics). In situ hybridization was carried out using this DIG-labeled probe, following the previously reported procedure (19) . Hybridization signals were visualized using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium substrate (Roche). The color was allowed to develop overnight in the dark. The subdivisions and nomenclature of brain nuclei were taken from medaka brain atlases (20, 21) .
Coexpression analysis of tcn and crh in the medaka brain
To examine whether tcn is coexpressed in the same neurons that express crh, double in situ hybridization was performed as described elsewhere (22) . In brief, whole brains (n ϭ 5) were fixed in 4% paraformaldehyde and embedded in 5% agarose (Type IX-A; Sigma-Aldrich) supplemented with 20% sucrose. Embedded brains were frozen and cut into 20-m coronal sections. An 840-bp fragment corresponding to nucleotides 12-851 of the medaka crh cDNA (GenBank accession number, NM_001128518) was labeled with fluorescein using Fluorescein RNA Labeling Mix and T7 RNA polymerase (Roche). The brain sections were hybridized with the fluorescein-labeled crh probe and the DIG-labeled tcn probe described above. The fluoresceinlabeled crh probe was visualized using the TSA Plus Fluorescein System (PerkinElmer) and the DIG-labeled tcn probe was visualized using Fast Red (Roche). Images were captured by a confocal laser scanning microscope (TCS SP8; Leica Microsystems). The excitation and emission wavelengths for detection were as follows: 4Ј,6-diamidino-2-phenylindole for nuclear staining, 405 and 410 -480 nm; fluorescein, 488 and 495-545 nm; and Fast Red, 552 and 620 -700 nm.
Examination of tcn expression in medaka peripheral tissues
The expression of tcn was examined in a wide variety of medaka peripheral tissues. Total RNA was extracted from the eye, gill, heart, intestine, liver, spleen, kidney, muscle, skin, testis, and ovary, as well as the brain (n ϭ 6 for each tissue except for testis, where n ϭ 5), using Isogen (Nippon Gene). One microgram of deoxyribonuclease-treated RNA was reverse-transcribed to cDNA using the High Capacity cDNA Reverse Transcription kit (Life Technologies). Real-time PCR was performed using LightCycler 480 SYBR Green I Master on a LightCycler 480 System II (Roche). The expression of elongation factor 1␣ (eef1a) in each sample was used to normalize the expression of tcn by the standard curve method. PCR primers for tcn were TCN-F3 (5Ј-GGCTGT-GAGATGAAGGTGAAAGTG-3Ј) and TCN-R3 (5Ј-GGCCTA-CAGCGGTGTGTGA-3Ј). For eef1a, primers were EEF1A-F1 (5Ј-GGGAAAGGAAAAAATCCACATTAA-3Ј) and EEF1A-R1 (5Ј-GACCGGTGGAGGTGGACTT-3Ј).
Receptor activation assay for Tcn
To identify Crh receptors in medaka, BLAST searches were conducted against the GenBank, Ensembl, and National BioResource Project Medaka databases (http://www.shigen.nig.ac.jp/ medaka/), using catfish (Ameiurus nebulosus) Crh receptor sequences (23) as queries. This resulted in the identification of 2 predicted Crh receptor genes in medaka (Ensembl ID, EN-SORLG00000012904 and ENSORLG00000017621). The missing 5Ј exons and erroneous exon/intron boundaries of EN-SORLG00000012904 were corrected by referring to the sequence of an expressed sequence tag clone (NBRP ID, OLA04-Jp21) and alignment with catfish Crh receptor sequences, respectively. The corrected sequences of the predicted coding regions of these 2 genes are shown in Supplemental Figure 1 . The accuracy of these sequences was confirmed by PCR amplification using medaka brain poly(A) ϩ RNA as a template, followed by sequencing of the products as described above. Phylogenetic analysis of these sequences was carried out as described above in order to verify that they encode medaka Crhr1 and Crhr2. The species names and GenBank accession numbers of the sequences that were used in the analysis are listed in Supplemental Table 2 .
Medaka Crh and Tcn peptides with amidated C termini were synthesized by Scrum. The cDNA fragments encoding the fulllength Crhr1 and Crhr2 were PCR amplified and subcloned into the expression vector pcDNA3.1/V5-His-TOPO (Life Technologies). HEK293T cells were transiently transfected with 1 of the 2 Crh receptor expression constructs, a cAMP-responsive luciferase reporter vector pGL4.29 (Promega), and an internal control vector pGL4.74 (Promega) at a ratio of 11:18:1 using Lipofectamine LTX (Life Technologies). Forty-two hours after transfection, cells were treated with peptide at doses of 0M, 10 Ϫ11 M, 10 Ϫ10 M, 10 Ϫ9 M, 10 Ϫ8 M, 10 Ϫ7 M, 10 Ϫ6 M, and 10 Ϫ5 M in Dulbecco's modified Eagle medium (Life Technologies) for 6 hours. The extracted cells were assayed for luciferase activity using the Dual-Luciferase Reporter Assay System (Promega). Assays were performed in triplicate and independently repeated 3 times. Data obtained were analyzed using GraphPad Prism (GraphPad Software).
Results
Identification of tcn as a novel, teleost-specific member of the CRH family of peptides
In silico screening of the medaka genome, followed by cloning and sequencing of the full-length cDNA, led to the identification of a gene, which we designated tcn. This gene was highly homologous to, but distinct from, known CRH family genes. The medaka tcn cDNA (deposited in DDBJ/ EMBL/GenBank with accession number LC002816) was 914 bp in length, excluding the poly (A) ϩ tail, and encoded a 144-amino acid protein ( Figure 1A) . Amino acid sequence analysis of medaka Tcn predicted a signal peptide at the N terminus with a cleavage site between residues 22 and 23, and a 41-amino acid mature Tcn peptide at the C terminus. The mature peptide was flanked by a typical proteolytic cleavage site, Lys-X-Lys-Arg (where X is any amino acid), at the N terminus and by an amidation signal, Gly-Lys, at the C terminus. The medaka tcn gene, located on chromosome 17, consisted of 2 exons separated by an intron of 1.3 kb, with the entire open reading frame contained in the second exon. These structural features are common to all known members of the CRH family of peptides (24) . Although the mature peptide of medaka Tcn had a high degree of sequence identity with those of known CRH family members (eg, 73% identity with that of medaka Crh), other regions of the precursor protein showed no such sequence identity (Supplemental Figure 2 and Supplemental Table 3 ). A database search using this medaka sequence as a query led to the identification of possible tcn orthologs in several other teleost species. These species included, for instance, stickleback (Gasterosteus aculeatus) (scaffold 120:91371-91757 of the stickleback genome assembly, Ensembl release 77) and tilapia (Oreochromis niloticus) (GL831416.1:378983-379414 of the tilapia genome assembly, Ensembl release 77) ( Figure 1A ). However, no potential orthologs were found in other teleost species, including zebrafish (Danio rerio), fugu (Takifugu rubripes), and cod (Gadus morhua), and other vertebrate taxa, including tetrapods.
Subsequent phylogenetic and synteny analyses confirmed that the identified stickleback and tilapia genes are orthologous to medaka tcn: they lay on the same phylogenetic subbranch as, and shared conserved synteny with, medaka tcn (Figure 1, B and C) . Phylogenetic analysis showed that Tcn is a member of the CRH family, but forms an independent subbranch within this family ( Figure 1B) . The analysis further indicated that Tcn is most closely related to, but clearly distinct from, Crh. Two Crh paralogs, here named Crha and Crhb, were identified in the teleost lineage, but Tcn is distinct from both of them (Supplemental Figure 3 ). Both Crha and Crhb have been identified in some teleost species (including salmon (Salmo salar), smelt (Osmerus mordax), cod, and zebrafish), but not others (including medaka, tilapia, stickleback, and fugu). Tcn is also distinct from elephant shark Crh2, which has recently been predicted from the genome sequence (11) . Synteny analysis revealed that tcn lies adjacent to
press.endocrine.org/journal/endoadhfe1, trim55, and dnajc5b in the genome ( Figure 1C ). This syntenic relationship was also found for CRH and UCN/uts1 genes.
Expression of tcn in the medaka brain and its colocalization with crh
In the medaka brain, neurons expressing tcn were identified in the next 5 nuclei: the lateral nucleus of the ventral telencephalic area (Vl) in the telencephalon, the magnocellular portion of the magnocellular preoptic nucleus (PMm) in the preoptic area, the ventral tuberal nucleus (NVT) in the hypothalamus, the nucleus of the oculomotor nerve (NIII) in the tegmentum, and the secondary gustatory nucleus (NGS) in the isthmic region (Figure 2) . The most prominent expression occurred in Vl, where a relatively large number of tcn-expressing neurons were regionally clustered. In the other 4 nuclei, tcn-expressing neurons were found scattered singly or in small clusters consisting of only a few neurons. No tcn-expressing cells were detected in the pituitary.
The simultaneous detection of tcn and crh expression revealed that in all 5 nuclei, virtually all tcn-expressing neurons also expressed crh (Figure 3 ). In addition, we observed some cells that were morphologically distinct from neurons and expressed tcn but not crh. These cells were scattered throughout the brain and had small, oval-shaped nuclei surrounded by scant cytoplasm (Figure 3) .
It is highly unlikely that the in situ hybridization probes for tcn and crh would cross-react, considering that tcn and crh have a low degree of sequence identity except for the mature peptide-coding region (the tcn probe shared 62% overall nucleotide identity with the crh cDNA; the crh probe, 59% identity with the tcn cDNA) and that in situ hybridization was performed using a high stringency procedure to minimize nonspecific hybridization (both hybridization and washing were performed in the presence of 50% formamide at 55°C) (19) . Indeed, the tcn and crh probes gave different distributions of hybridization signals, even in the same neurons.
Expression of tcn in medaka peripheral tissues
Expression of tcn was apparent in all peripheral tissues examined except the intestine, where the expression was detectable in only 1 of 6 samples ( Figure 4) . Relatively high levels of expression were observed in the eye and muscle (175-and 51-fold higher than in the brain, respectively).
Comparison of the abilities of medaka Crh and Tcn, with regard to the activation of Crh receptors
We investigated whether Tcn can function as a ligand for Crh receptors, and its effectiveness as compared with Crh. Medaka crhr1 and crhr2 were identified in silico, and their sequences were verified by cloning and sequencing. Phylogenetic analysis confirmed that these genes encoded medaka Crhr1 (or possibly Crhr3, which is closely related to Crhr1 and has been found only in catfish) (23) and Crhr2 (Supplemental Figure 4) . HEK293T cells transiently expressing these medaka Crh receptors were then tested for responsiveness to medaka Tcn and Crh peptides. Tcn and Crh each activated both Crhr1 and Crhr2 in a dose-dependent manner, as measured by an increase in cAMP-dependent luciferase activity ( Figure 5 ). Tcn activated both receptors with a comparable or slightly higher potency than Crh. Both Tcn and Crh were an order of magnitude more potent in activating Crhr1 (EC 50 : Tcn, 0.19nM and Crh, 0.58nM) than they were in activating Crhr2 (EC 50 : Tcn, 3.4nM and Crh, 7.5nM). However, the maximal levels of luciferase activity induced by Crhr2 activation (Tcn, 450-fold above baseline; Crh, 360-fold above baseline) were an order of magnitude greater than those induced by Crhr1 activation (Tcn, 28-fold above baseline; Crh, 29-fold above baseline).
Discussion
We identified a previously undescribed member of the CRH family of peptides. It appears to occur exclusively in teleosts and was designated Tcn due to this teleost-specific occurrence. In addition to sequence similarity, Tcn shares structural features with known members of the CRH family, including a signal peptide and N-terminal cleavage and C-terminal amidation sites for the mature peptide. We also demonstrated that Tcn is expressed in several brain nuclei and can activate 2 Crh receptors. These lines of evidence strongly suggest that Tcn is a functional member of the CRH family of peptides.
Tcn may only be found in teleosts due to a whole-genome duplication event that occurred early in the evolution of teleosts, after their divergence from tetrapods (25) . Of the members of the CRH family peptides, Tcn is structurally most closely related to Crh and it is reasonable to assume that tcn is a teleost-specific duplicate of crh that originated from the teleost-specific genome duplication. However, tcn is clearly distinct from both of the crh paralogs that we identified in some but not all teleost species (designated crha and crhb), which likely arose from the teleost-specific genome duplication, but were later lost in certain species. Phylogenetic analysis also suggested that the duplication that gave rise to tcn and crh likely occurred before the teleost-tetrapod split. This is supported by the high bootstrap value (984/1000) at the corresponding node. In addition, phylogenetic analysis of trim55, a conserved gene found adjacent to tcn/crh in various genomes, gave essentially the same result as that of CRH family press.endocrine.org/journal/endopeptides (Supplemental Figure 5) . These results suggest that tcn did not arise from a teleost-specific genome duplication, but was instead derived from an earlier duplication in an ancestral vertebrate. Nevertheless, no tcn-like sequence could be found in any tetrapods. Given that tcn was not found in coelacanths or Xenopus, this gene was most likely lost in the tetrapod lineage shortly after its divergence from the teleost lineage. In addition, tcn-like sequences could not be found in zebrafish, fugu, or cod, suggesting that some teleost species may have lost tcn relatively recently. Both the conserved synteny of the tcn/crh loci involving adhfe1, trim55, and dnajc5b and the absence of a duplicate for any of these genes in these teleosts and tetrapods suggest that the emergence and loss of tcn did not occur at the single gene level, but rather involved a longer chromosome segment. Although less likely, the possibility that tcn arose within the teleost lineage cannot be fully excluded, and further studies are thus needed to determine the exact origin of tcn.
Only a single crh-like gene has been identified in tunicates, which represent the closest living relatives of vertebrates (26, 27) . It is generally accepted that crh, ucn (including uts1/sauvagine), ucn2, and ucn3 were generated by 2 rounds of whole-genome duplication early in vertebrate ancestry (8) . This, combined with our phylogenetic results, suggests that the duplication of an ancestral crh that gave rise to tcn and crh occurred after the 2-round whole-genome duplication but before the divergence of teleosts and tetrapods.
Another novel member of the CRH family gene, crh2, has recently been predicted from the elephant shark genome (11) . This gene is suggested to have arisen during the early radiation of cartilaginous fish, and should thus be unique to them (11) . Although the elephant shark genome is evolving much more slowly than that of any other vertebrate (28), Crh2 lacks several sequence motifs that are highly conserved between Tcn and Crh. Consequently, the deduced mature peptide sequence of medaka Tcn exhibits greater identity to that of elephant shark Crh (68%) than to that of elephant shark Crh2 (58%) (although the exact sequence of the mature Tcn peptide has yet to be confirmed by isolating and characterizing the peptide). These lines of evidence indicate that crh2 is not orthologous to tcn, and that crh2 diverged from tcn/crh before the divergence of tcn and crh. This notion is further supported by the present phylogenetic analysis.
We demonstrated that tcn-expressing neurons reside in the next 5 nuclei of the medaka brain: Vl, PMm, NVT, NIII, and NGS. Teleosts do not have a hypothalamic-pituitary portal system; hypophysiotropic neurons directly innervate their target cells in the pituitary (29) . None of the Neurons expressing tcn were most abundant in Vl, and fewer were found in PMm, NVT, NIII, and NGS. In the brains of tilapia fish (Oreochromis mossambicus), Vl also contains the largest population of Crh-immunoreactive neurons, which project to the lateral nucleus of the dorsal telencephalic area (33) . The lateral nucleus of the dorsal telencephalic area is considered to be homologous to the medial pallium/hippocampus of tetrapods and is involved in spatial and temporal learning (34, 35) . Tcn, as well as Crh, produced in Vl may be relevant to the stress-modulation of learning ability. It has been suggested that Vl is a homolog of the septal nuclei/Meynert's basal nucleus of mammals; however, this relationship is controversial (36 -39) . In the lateral septum of rodents, few, if any, neurons express CRH family peptides. Instead, many of the neurons in the lateral septum are innervated by CRH family peptide-expressing neurons and express CRHR2, which plays a critical role in mediating stress-induced, anxietyrelated behavior (40, 41) . Although the expression of Crh receptors in Vl remains unexamined, Tcn produced in Vl may be involved in stress-induced, anxiety-related behavior in an autocrine/paracrine manner. On the other hand, PMm has been implicated in reproductive behavior and receives innervation from NVT (42, 43) . The expression of tcn in these 2 nuclei suggests that it may be involved in the control of reproductive behavior, whereas that in NIII and NGS implies a tcn-mediated modulation of sensory inputs. Further studies are required to uncover the role of tcn expression in these nuclei.
A population of nonneuronal cells also expressed tcn. These cells appear to be hemocytes, based on their size and morphology. This observation suggests that tcn serves some function in the circulatory or immune systems. CRH is produced in leukocytes and profoundly influences the function of the immune system through local modulatory actions on inflammatory responses (44 -46) . Given that these tcn-expressing cells do not coexpress crh, subfunctionalization has probably occurred between tcn and crh via the partitioning of spatial domains of expression. This subfunctionalization may explain the survival of both tcn and crh in the teleost lineage.
We also found that tcn is expressed in a wide range of peripheral tissues. tcn was abundantly expressed in the eye and muscle, whereas expression in the brain was relatively low. The low level of tcn expression in the brain probably reflects the fact that the expression is confined to a small number of neurons. In the eye, where the highest tcn expression was observed, CRH family peptides have been shown to be expressed in amacrine and retinal ganglion cells of several vertebrate species (47) (48) (49) (50) (51) (52) . Although little information is available on the role of CRH family peptides in the eye, it has been shown that intraocular administration of UCN2 prevents ischemia-induced retinal cell loss (53) . Tcn may have a similar protective function in the eye. Considering also the expression in NIII, Tcn likely plays an important role in the visual system. In the mouse muscle, UCN2 has been shown to modulate glucose uptake and insulin sensitivity (54) . It would be worth investigating whether Tcn has a similar role in the muscle.
Tcn activated both medaka Crhr1 and Crhr2 at picomolar to nanomolar concentrations. This result, together with the apparent expression of tcn in the brain, indicates that Tcn is a functional endogenous ligand for these receptors. Tcn was found to be equally or slightly more potent than Crh at both receptors. Therefore, in addition to being similar in structure and expression, Tcn and Crh have similar receptor interaction properties, further suggesting that they have common functions. Like mammalian CRH, both Tcn and Crh activated Crhr1 at lower doses than were required to activate Crhr2 (10) . This suggests a conserved receptor preference for Tcn and Crh. In press.endocrine.org/journal/endocontrast, UCN exhibits nearly equal affinities for both CRHR1 and CRHR2, and UCN2/UCN3 are highly selective in favor of CRHR2 (4, 5, 7) . In the present study, Crhr2 reached a markedly higher maximal activation than Crhr1 in response to both Tcn and Crh. No such results have been reported for tetrapods; therefore, this may be a property unique to the Crh receptors of teleosts. Crhr1 and Crhr2 in teleosts may serve distinct physiological roles by virtue of their differences in sensitivity and maximal response. In summary, in this study, we have identified Tcn as a novel member of the CRH family of peptides that appears to be present only in teleost fish. Our findings indicate that Tcn is a functional member of the CRH family with physiological properties that resemble Crh, and may contribute to the regulation of central stress responses. Further study of Tcn should provide useful insights into the molecular basis and evolution of vertebrate stress responses that would not otherwise be available.
